Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 16;14(16):1797.
doi: 10.3390/diagnostics14161797.

Aqueous Humor Cytokines in Idiopathic Epiretinal Membrane: Correlation with Disease Severity

Affiliations

Aqueous Humor Cytokines in Idiopathic Epiretinal Membrane: Correlation with Disease Severity

Tommaso Torresin et al. Diagnostics (Basel). .

Abstract

Background: To analyze the concentration of aqueous humor (AH) cytokines in eyes with idiopathic epiretinal membrane (iERM) and to investigate their potential correlation with disease severity.

Methods: Retrospective cross-sectional case-control institutional study. A total of 16 eyes of 16 iERM patients and 14 eyes of 14 age-matched healthy controls were enrolled. AH samples were analyzed for various biomarkers using a glass-chip protein array. Cytokines associated with inflammation, fibrosis, angiogenesis, and glial signal transduction were quantified.

Results: Significant differences in cytokine concentration were observed between the iERM group and controls, with 19 cytokines elevated in the iERM group (among them IL-6, IL-8, PDGF-AB, PDGF-BB, TGFB-1, TGFB-2, TGFB-3, VEGF A, VEGF C, VEGF D, p < 0,05, 95% confidence interval). Correlation analysis revealed associations between cytokine levels and iERM severity. Notably, stages 2, 3, and 4 of iERM demonstrated increased levels of various biomarkers.

Conclusions: This study provides insights into the complex molecular interactions underlying iERM pathogenesis, describing a correlation between neuroinflammation and iERM severity.

Keywords: aqueous humor; cytokines; epiretinal membrane; proteomics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Comparison of significant cytokines concentration in iERM and Healthy Control (HC) groups. IL-6: Interleukin-6; IL-8: Interleukin-8; TARC (CCL17): Thymus and Activation-Regulated Chemokine; FRACTALKINE (CX3CL1): Fractalkine (C-X3-C Motif Chemokine Ligand 1); GDNF: Glial Cell Line-Derived Neurotrophic Factor; GM-CSF: Granulocyte-Macrophage Colony-Stimulating Factor; GROa (CXCL1): Growth-Regulated Alpha Protein (C-X-C Motif Chemokine Ligand 1); MIF: Macrophage Migration Inhibitory Factor; PDGF-AB: Platelet-Derived Growth Factor-AB; PDGF-BB: Platelet-Derived Growth Factor-BB; TGFβ-3: Transforming Growth Factor Beta-3; TGFβ-1: Transforming Growth Factor Beta-1; TGFβ-2: Transforming Growth Factor Beta-2; VEGF A: Vascular Endothelial Growth Factor A; VEGF C: Vascular Endothelial Growth Factor C; VEGF D: Vascular Endothelial Growth Factor D; IL-12p40: Interleukin-12 Subunit p40; IL-12p70: Interleukin-12 p70; MIF: Macrophage Migration Inhibitory Factor.
Figure 2
Figure 2
% normalized correlation between iERM stage and significant cytokine concentrations. Note the positive correlation between cytokine levels and the iERM stage, indicating that higher cytokine concentrations are associated with more advanced stages of iERM. IL-6: Interleukin-6; IL-8: Interleukin-8; GM-CSF: Granulocyte-Macrophage Colony-Stimulating Factor; IL-12p40: Interleukin-12 Subunit p40; IL-12p70: Interleukin-12 p70; MIF: Macrophage Migration Inhibitory Factor; TGFβ-1: Transforming Growth Factor Beta-1; TGFβ-2: Transforming Growth Factor Beta-2; TGFβ-3: Transforming Growth Factor Beta-3; VEGF A: Vascular Endothelial Growth Factor A; VEGF C: Vascular Endothelial Growth Factor C; VEGF D: Vascular Endothelial Growth Factor D; TARC (CCL17): Thymus and Activation-Regulated Chemokine (CCL17); FRACTALKINE (CX3CL1): Fractalkine (C-X3-C Motif Chemokine Ligand 1); GROa (CXCL1): Growth-Regulated Alpha Protein (C-X-C Motif Chemokine Ligand 1); PDGF-AB: Platelet-Derived Growth Factor-AB; PDGF-BB: Platelet-Derived Growth Factor-BB; GDNF: Glial Cell Line-Derived Neurotrophic Factor.

References

    1. Brinkmann M.P., Michels S., Brinkmann C., Rommel F., Ranjbar M., Graf Johansen N., Becker M. Epiretinal Membrane Surgery Outcome in Eyes with Abnormalities of the Central Bouquet. Int. J. Retina Vitreous. 2021;7:7. doi: 10.1186/s40942-020-00279-0. - DOI - PMC - PubMed
    1. Ng C.H., Cheung N., Wang J.J., Islam A.F.M., Kawasaki R., Meuer S.M., Cotch M.F., Klein B.E.K., Klein R., Wong T.Y. Prevalence and Risk Factors for Epiretinal Membranes in a Multi-Ethnic United States Population. Ophthalmology. 2011;118:694–699. doi: 10.1016/j.ophtha.2010.08.009. - DOI - PMC - PubMed
    1. Govetto A., Lalane R.A., Sarraf D., Figueroa M.S., Hubschman J.P. Insights Into Epiretinal Membranes: Presence of Ectopic Inner Foveal Layers and a New Optical Coherence Tomography Staging Scheme. Am. J. Ophthalmol. 2017;175:99–113. doi: 10.1016/j.ajo.2016.12.006. - DOI - PubMed
    1. Schumann R.G., Gandorfer A., Ziada J., Scheler R., Schaumberger M.M., Wolf A., Kampik A., Haritoglou C. Hyalocytes in Idiopathic Epiretinal Membranes: A Correlative Light and Electron Microscopic Study. Graefes Arch. Clin. Exp. Ophthalmol. 2014;252:1887–1894. doi: 10.1007/s00417-014-2841-x. - DOI - PubMed
    1. Tanikawa A., Shimada Y., Horiguchi M. Comparison of Visual Acuity, Metamorphopsia, and Aniseikonia in Patients with an Idiopathic Epiretinal Membrane. Jpn. J. Ophthalmol. 2018;62:280–285. doi: 10.1007/s10384-018-0581-x. - DOI - PubMed

LinkOut - more resources